Lexeo Therapeutics Inc (LXEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 23,550 | 23,291 | 14,975 | 20,273 | 13,975 |
| Operating Income | -23,550 | -23,291 | -14,975 | -20,273 | -13,975 |
| Interest Expense | 35 | 37 | 50 | 52 | 53 |
| Other Income | 2,347 | 1,646 | 837 | 217 | 587 |
| Pre-tax Income | -21,238 | -21,682 | -14,188 | -20,108 | -13,441 |
| Net Income Continuous | -21,238 | -21,682 | -14,188 | -20,108 | -13,441 |
| Net Income | $-21,238 | $-21,682 | $-14,188 | $-20,108 | $-13,441 |
| EPS Basic Total Ops | -0.64 | -0.77 | 19.84 | -12.36 | -8.30 |
| EPS Basic Continuous Ops | -0.64 | -0.77 | 19.84 | -12.36 | -8.30 |
| EPS Diluted Total Ops | -0.64 | -0.77 | 19.84 | -12.36 | -8.30 |
| EPS Diluted Continuous Ops | -0.64 | -0.77 | 19.84 | -12.36 | -8.30 |
| EPS Diluted Before Non-Recurring Items | -0.64 | -0.77 | -0.86 | N/A | N/A |
| EBITDA(a) | $-23,473 | $-23,222 | $-14,898 | $-20,195 | $-14,306 |